LabCompass

Andrew J. Brooks

Physics and Astronomy · Indiana University

Publications

191

Citations

4,321

Est. group size

Recurring co-author estimate

Active years

48

Publishing since 1979

Research summary
AI-generated

Andrew J. Brooks studies how cells send and receive chemical signals, focusing on cytokine and growth-hormone receptors (such as GP130 and the growth hormone receptor) and the enzymes (kinases) that control their activity. Much of this work connects to cancer immunotherapy, including engineering immune cells like natural killer (NK) cells and antibody-based approaches to target tumors. The research spans molecular mechanisms of receptor signaling through to potential clinical applications.

Cytokine and growth-hormone receptor signalingKinase regulation and cell signalingCancer immunotherapy (NK cells, CAR approaches)Immune cell biology (dendritic/Langerhans cells)Molecular therapeutics and antibody engineering

Publication activity has been relatively steady but modest over the last decade, averaging about 3.4 papers per year in the most recent five years, down from higher counts earlier in the period.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.4/year recently
2017: 8 publications8172018: 5 publications182019: 8 publications8192020: 5 publications202021: 4 publications212022: 2 publications222023: 5 publications232024: 5 publications242025: 4 publications252026: 1 publication26
Recent publications
Publishes in
  • Nature Communications×4
  • Endocrinology×4
  • Blood×3
  • ANZ Journal of Surgery×3
  • Developmental Cell×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile